🇺🇸 Floseal hemostatic matrix in United States

14 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 14

Most-reported reactions

1. Post Procedural Complication — 4 reports (28.57%)
2. Status Epilepticus — 2 reports (14.29%)
3. Blood Bilirubin Increased — 1 report (7.14%)
4. Blood Pressure Decreased — 1 report (7.14%)
5. Death — 1 report (7.14%)
6. End-Tidal Co2 Decreased — 1 report (7.14%)
7. Hypotension — 1 report (7.14%)
8. Ileus Paralytic — 1 report (7.14%)
9. Intracranial Pressure Increased — 1 report (7.14%)
10. Oxygen Saturation Decreased — 1 report (7.14%)

Source database →

Frequently asked questions

Is Floseal hemostatic matrix approved in United States?

Floseal hemostatic matrix does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Floseal hemostatic matrix in United States?

Chang Gung Memorial Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.